BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $649,000 | +70.3% | 503,151 | +38.7% | 0.00% | – |
| Q3 2019 | $381,000 | -39.5% | 362,657 | -2.2% | 0.00% | -100.0% |
| Q2 2019 | $630,000 | -47.7% | 370,743 | +3.7% | 0.00% | 0.0% |
| Q1 2019 | $1,204,000 | +15.2% | 357,425 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $1,045,000 | -52.5% | 357,710 | +0.2% | 0.00% | -50.0% |
| Q3 2018 | $2,199,000 | -15.4% | 356,971 | +1.4% | 0.00% | 0.0% |
| Q2 2018 | $2,600,000 | +147.6% | 352,216 | +120.0% | 0.00% | +100.0% |
| Q1 2018 | $1,050,000 | +52.2% | 160,100 | +95.2% | 0.00% | 0.0% |
| Q4 2017 | $690,000 | -29.8% | 82,030 | -3.6% | 0.00% | 0.0% |
| Q3 2017 | $983,000 | -0.8% | 85,095 | +0.3% | 0.00% | 0.0% |
| Q2 2017 | $991,000 | -3.7% | 84,820 | +1.8% | 0.00% | 0.0% |
| Q1 2017 | $1,029,000 | -8.7% | 83,338 | +0.7% | 0.00% | 0.0% |
| Q4 2016 | $1,127,000 | -28.9% | 82,728 | +3.8% | 0.00% | -50.0% |
| Q3 2016 | $1,586,000 | +72.2% | 79,691 | +12.2% | 0.00% | +100.0% |
| Q2 2016 | $921,000 | +36.6% | 71,027 | -1.4% | 0.00% | 0.0% |
| Q1 2016 | $674,000 | -56.1% | 72,032 | -4.9% | 0.00% | -50.0% |
| Q4 2015 | $1,535,000 | +39.7% | 75,719 | +0.2% | 0.00% | 0.0% |
| Q3 2015 | $1,099,000 | -30.7% | 75,581 | +1.4% | 0.00% | 0.0% |
| Q2 2015 | $1,586,000 | -2.0% | 74,573 | +6.8% | 0.00% | 0.0% |
| Q1 2015 | $1,619,000 | +0.6% | 69,857 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $1,610,000 | – | 69,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|